UA110280C2 - Micellar composition for delivery of cancer drugs - Google Patents
Micellar composition for delivery of cancer drugsInfo
- Publication number
- UA110280C2 UA110280C2 UAA201405945A UAA201405945A UA110280C2 UA 110280 C2 UA110280 C2 UA 110280C2 UA A201405945 A UAA201405945 A UA A201405945A UA A201405945 A UAA201405945 A UA A201405945A UA 110280 C2 UA110280 C2 UA 110280C2
- Authority
- UA
- Ukraine
- Prior art keywords
- delivery
- micellar
- anticancer drug
- polyethyleneoa
- cooh
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Винахід стосується міцелярної композиції для доставки протиракового препарату, що як міцелярні носії протиракового препарату містить частково гідролізовані подвійні гідрофільні диблок- або триблок-кополімери (ДБК-СООН або ТБК-СООН) поліакриламіду та метоксиполіетиленоксиду або поліетиленоксиду (МОПЕО--ПАА або ПАА--ПЕО--ПАА) з хімічно комплементарними блоками різної довжини, які утворюють інтрамолекулярні полікомплекси та міцелярні структури моно- і полімолекулярного типів, а як протираковий препарат містить гідрохлорид доксорубіцину.The invention relates to a micellar composition for the delivery of an anticancer drug, which as a micellar carrier of the anticancer drug contains partially hydrolyzed double hydrophilic diblock or triblock copolymers (DBK-COOH or TBK-COOH) polyacrylamide and methoxypolyethyleneOA or polyethyleneOA or polyethyleneOA - PAA) with chemically complementary blocks of different lengths, forming intramolecular polycomplexes and micellar structures of mono- and polymolecular types, and containing doxorubicin hydrochloride as an anticancer drug in.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
UA110280C2 true UA110280C2 (en) | 2015-12-10 |
Family
ID=55171491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201405945A UA110280C2 (en) | 2014-05-30 | 2014-05-30 | Micellar composition for delivery of cancer drugs |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA110280C2 (en) |
-
2014
- 2014-05-30 UA UAA201405945A patent/UA110280C2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123953T1 (en) | DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE | |
EA201790024A1 (en) | MODULATORS OF TOLL-LIKE RECEPTORS FOR HIV TREATMENT | |
EP3315608A4 (en) | Sirna, pharmaceutical composition and conjugate which contain sirna, and uses thereof | |
DK3283521T3 (en) | DRUG CONJUGATES INCLUDING ANTIBODIES TO CLAUDIN 18.2 | |
MA41265A (en) | COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS. | |
EP3302265A4 (en) | Drug delivery capsule | |
AU2013225533A8 (en) | Amido spirocyclic amide and sulfonamide derivatives | |
WO2014153030A3 (en) | Methods of treating cancer and preventing cancer drug resistance | |
CY1121999T1 (en) | PHARMACEUTICAL FORMS OF DARUNAVIR COMBINATION | |
EA201791454A1 (en) | DRUG FORMS FOR TRANSDERMAL ADMINISTRATION | |
WO2014144295A8 (en) | Ceftolozane antibiotic compositions | |
TR201821116A2 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING POSACONAZOL AND THE MANUFACTURING METHOD | |
CY1119446T1 (en) | PHARMACEUTICAL FORMS DARUNAVIRIS | |
CY1120098T1 (en) | COMPOSITIONS CONTAINING BORTIOXETINE AND GONES | |
PH12017501084A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
UA116889C2 (en) | COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS | |
BR112016014880A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDING PALONOSETRON | |
EA201791600A1 (en) | DERIVATIVES OF HYDROXIALKILPIPERASINE AS RECESSOR CXCR3 MODULATORS | |
MX2017012596A (en) | A pharmaceutical composition and the use thereof. | |
TR201901977T4 (en) | (R) -2-methyl-piperazine derivatives as Cxcr3 receptor modulators. | |
EA201991287A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE | |
AU2015303724B2 (en) | Quinazoline derivative | |
EP3453390A4 (en) | Polymerized drug-containing pharmaceutical composition | |
EP3326628A4 (en) | Pharmaceutical composition for oral administration comprising high concentration taxane | |
CY1120192T1 (en) | UNIONS TO ENHANCE KNOWLEDGE FUNCTIONING |